Wordt geladen...
Cystic Fibrosis Therapeutics: The Road Ahead
A great deal of excitement and hope has followed the successful trials and US Food and Drug Administration approval of the drug ivacaftor (Kalydeco), the first therapy available that targets the underlying defect that causes cystic fibrosis (CF). Although this drug has currently demonstrated a clini...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American College of Chest Physicians
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3610617/ https://ncbi.nlm.nih.gov/pubmed/23276843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.12-1639 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|